{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:08:39Z","timestamp":1744178919217},"reference-count":12,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2014.00675","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T15:30:47Z","timestamp":1420471847000},"source":"Crossref","is-referenced-by-count":5,"title":["Analysis of Specific IgG Titers Against Tick-Borne Encephalitis in Patients with Primary Antibody Deficiency Under Immunoglobulin Substitution Therapy: Impact of Plasma Donor Origin"],"prefix":"10.3389","volume":"5","author":[{"given":"Sigune","family":"Goldacker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Huzly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schlesier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Hartmut","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Warnatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,1,5]]},"reference":[{"issue":"39","key":"B1","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.39.19976-en","article-title":"Working group for Tick-borne encephalitis virus C. Tick-borne encephalitis in Europe, 2007 to 2009","volume":"16","author":"Donoso Mantke","year":"2011","journal-title":"Euro Surveill"},{"issue":"4","key":"B2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1128\/CVI.05705-11","article-title":"Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations","volume":"19","author":"Rabel","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"40","key":"B3","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1016\/j.vaccine.2010.07.027","article-title":"Vaccination against tick-borne encephalitis virus tests specific IgG production ability in patients under immunoglobulin substitution therapy","volume":"28","author":"Seidel","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"B4","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"issue":"1","key":"B5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"issue":"2","key":"B6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jcv.2009.03.016","article-title":"Highly specific detection of antibodies to tick-borne encephalitis (TBE) virus in humans using a domain III antigen and a sensitive immune complex (IC) ELISA","volume":"45","author":"Ludolfs","year":"2009","journal-title":"J Clin Virol"},{"issue":"9\u00e2\u20ac\u201c10","key":"B7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10354-010-0798-x","article-title":"TBE \u00e2\u20ac\u201c awareness and protection: the impact of epidemiology, changing lifestyle, and environmental factors","volume":"160","author":"Kunze","year":"2010","journal-title":"Wien Med Wochenschr"},{"issue":"3","key":"B8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.clim.2007.04.011","article-title":"Active vaccination in patients with common variable immunodeficiency (CVID)","volume":"124","author":"Goldacker","year":"2007","journal-title":"Clin Immunol"},{"issue":"Pt 1","key":"B9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1099\/0022-1317-70-1-219","article-title":"Characterization of antigenic variants of tick-borne encephalitis virus selected with neutralizing monoclonal antibodies","volume":"70","author":"Holzmann","year":"1989","journal-title":"J Gen Virol"},{"issue":"2","key":"B10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.virol.2007.05.042","article-title":"Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus","volume":"366","author":"Gromowski","year":"2007","journal-title":"Virology"},{"issue":"26","key":"B11","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1016\/j.vaccine.2004.12.028","article-title":"Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein","volume":"23","author":"Mota","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"B12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00430-001-0107-9","article-title":"Cross-reactivity in flavivirus serology: new implications of an old finding?","volume":"190","author":"Allwinn","year":"2002","journal-title":"Med Microbiol Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T07:15:06Z","timestamp":1566198906000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2014.00675\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,5]]},"references-count":12,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2014.00675","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,5]]}}}